Galera Therapeutics, Inc. (GRTX)

Galera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	7	6	40	118	254	327
Market Cap Growth	-89.97%	-83.95%	-65.91%	-53.47%	-22.08%	40.53%
Enterprise Value	146	141	36	99	239	309
PE Ratio	-	-0.11	-0.65	-1.35	-3.43	-6.29
PS Ratio	83.44	-	-	-	-	-
PB Ratio	-0.07	-0.05	-0.37	-2.04	41.59	4.69
P/FCF Ratio	-0.24	-0.14	-0.93	-1.73	-4.24	-6.90
P/OCF Ratio	-0.24	-0.14	-0.93	-1.74	-4.27	-7.00
EV/Sales Ratio	1660.67	-	-	-	-	-
EV/EBITDA Ratio	-4.05	-3.01	-0.71	-1.36	-3.39	-6.10
EV/EBIT Ratio	-4.02	-2.99	-0.70	-1.35	-3.37	-6.06
EV/FCF Ratio	-3.89	-3.13	-0.83	-1.45	-3.99	-6.53
Debt / Equity Ratio	-1.12	-1.15	-1.28	-0.01	0.09	0.01
Debt / EBITDA Ratio	-4.17	-3.26	0.00	0.00	-0.01	-0.02
Debt / FCF Ratio	-4.00	-3.39	0.00	0.00	-0.01	-0.02
Quick Ratio	6.69	3.68	2.36	5.51	5.21	11.58
Current Ratio	7.54	4.36	2.88	5.98	5.58	12.13
Asset Turnover	0.00	0	0	0	0	0
Interest Coverage	0	4.11	-4.43	-10.20	-14.46	-16.72
Return on Equity (ROE)	33.97%	45.04%	56.99%	151.24%	-1213.11%	-74.60%
Return on Assets (ROA)	-232.83%	-226.01%	-141.30%	-105.30%	-88.25%	-42.09%
Return on Capital (ROIC)	-227.40%	-222.37%	46.94%	127.15%	-1060.63%	-71.96%
Earnings Yield	-623.09%	-912.12%	-154.17%	-74.11%	-29.17%	-15.90%
FCF Yield	-517.94%	-693.28%	-107.66%	-57.65%	-23.58%	-14.48%
Buyback Yield / Dilution	-54.54%	-64.47%	-5.03%	-3.70%	-0.23%	-28.15%
Total Shareholder Return	-54.54%	-64.47%	-5.03%	-3.70%	-0.23%	-28.15%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.